Founded in 2016, Qrons is a publicly traded, preclinical biotechnology company, developing advanced cell-based solutions to combat neurological injuries. While we are laser-focused on traumatic brain injury (TBI), our technology could potentially treat a wide range of neurodegenerative diseases.

Profile Description

Our TBI treatment integrates proprietary, engineered mesenchymal stem cells (MSCs), 3D printable scaffolding, smart materials and a novel delivery system.

We believe this combination will reduce neuronal loss and functional impairment and possibly regenerate brain tissue and function for TBI patients.

We are developing 3D printable smart material scaffolds, innovative mesenchymal stem cell lines and a novel delivery system to repair and regenerate neuronal damage.

We take a multidisciplinary approach, developing solutions that match the complexity of the conditions we seek to treat. Our unique approach will move our research forward.

Leave a Comment

Time limit is exhausted. Please reload the CAPTCHA.

Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec_
  • wp-settings-
  • wp-settings-time-

Decline all Services
Accept all Services